On a non-GAAP adjusted basis, excluding these costs, we reported net income of $31.1 million or $0.80 per share, down $39.8 million or $1.02 per share respectively in the prior year quarter.
On a GAAP basis, we reported net income of $30 million or $0.77 per share, which includes the $1.5 million of previously referenced non-routine costs on a pre-tax basis.
Visibility remains limited on how customers will proceed with operations, particularly if an additional wave of infections materializes into the fall and winter months.
